| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and CEO | President and CEO | Director
2 companies
Jacob Chacko is President and CEO at ORIC and has filed Form 4s across 2 companies. From April 2020 to December 2025, the filings on record show 2 open-market purchases and 22 sales. Jacob Chacko's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $5.6M at current prices.
Historically, Jacob Chacko's trades have earned a strong insider score of 77/100 across 41 rated trades. Over a 12-month horizon, 77.5% of those trades were profitable, with an average 12-month return of +45.0%.
The biggest single holding is ORIC (~$5.6M) as President and CEO. Net of sales, the ORIC filings show accumulation of 291,815 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 18, 2021 | ORIC Oric Pharmaceuticals, Inc. | President and CEO | Sell | 27,778 | $25.34 | $703,982.97 | -47.7% | -23.9% | -85.2% | |
| May 13, 2021 | ORIC Oric Pharmaceuticals, Inc. | President and CEO | Sell | 2,220 | $25.13 | $55,780.21 | -3.7% | -26.0% | -88.4% | |
| Apr 30, 2021 | ORIC Oric Pharmaceuticals, Inc. | President and CEO | Sell | 1,300 | $25.14 | $32,684.70 | -2.1% | -28.7% | -86.2% | |
| Apr 1, 2021 | ORIC Oric Pharmaceuticals, Inc. | President and CEO | Sell | 800 | $25.09 | $20,069.60 | -1.3% | -23.8% | -71.6% |